Pfizer gets early FTC clearance for Metsera acquisition
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Join SI Premium – FREE
Pfizer Inc. (NYSE: PFE) announced that the U.S. Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act for its pending acquisition of Metsera (NASDAQ: MTSR).
The FTC clearance satisfies the regulatory review requirements for the previously announced acquisition. The original waiting period was set to expire on November 7.
The information is based on a press release statement from Pfizer.
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsRelated Entities
Twitter, Definitive Agreement, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
